Ben Hartman on Morphogen's Comeback, Nick Walker's Equity, and the 10g Tyrosine Return | Episode #221

Ben Hartman, Founder and CEO of Morphogen Nutrition, returns for a third PricePlow Podcast appearance to discuss the brand's second rebrand, the Nick Walker equity partnership, the 10g L-Tyrosine return to AlphaGEN, and where the supplement industry is heading -- all in Episode #221.

Ben Hartman is back for his third visit to the PricePlow Podcast in Episode #221, and Morphogen Nutrition has never been in a stronger position. Ben walks through everything: the second rebrand's full backstory, a never-before-told story about a failed acquisition that nearly sold the company, the financial reckoning that followed, and how selling the building and moving to a 3PL model finally cleared the slate. He calls this the best formula work Morphogen has ever done, at the healthiest margins in company history.

The conversation covers AlphaGEN's return to 10g L-Tyrosine, why PRIME is the anchor of the entire health line, details like how he navigates AstraGin® and BioPerine® across a multi-product stack, and the surprising origin of CALM.

Then comes the main event: the Nick Walker equity partnership, explained in full, including some of the financial structure the internet has been speculating about. The episode closes with a frank look at the longevity wave ahead, the natural-vs.-enhanced debate, and a nostalgic look back at the golden age of stimulants.

Subscribe to the PricePlow Podcast on your favorite platform and sign up for Morphogen Nutrition news alerts before diving in.

Subscribe to the PricePlow Podcast on Your Favorite Service (RSS)

Apple Podcasts

Spotify

YouTube

https://blog.priceplow.com/podcast/ben-hartman-morphogen-nutrition-221

Video: Morphogen’s Second Rebrand, Nick Walker Equity, and the 10g Tyrosine Return

Podcast: Play in new window | Download (Duration: 1:42:49 — 91.1MB)

Detailed Show Notes: Ben Hartman on Morphogen’s Rebrand, the Nick Walker Deal, and Where Supplements Are Heading

• 0:00 – Introductions

  Ben Hartman's third visit to the show connects three chapters of Morphogen's story. His first appearance, Episode #033, introduced the brand's founding philosophy: everything you need in one scoop. His second, Episode #063, covered the first rebrand and label redesign. This conversation tackles the second rebrand, a full operational overhaul, and a landmark athlete deal.

  Table of Contents

  Toggle

  Mike opens by noting Morphogen Nutrition as one of his favorite sources for densely packed formulas. Ben confirms there's a lot to unpack: multiple product launches planned for the rest of 2026, new athletes already signed, and at least one more announcement within a week or two.

• 0:45 – The Second Rebrand: What Triggered It

  About four years ago, the first rebrand simply didn't land the way Ben had planned. The wrong people were in the wrong seats, and the result was years of survival mode that stretched through the post-COVID supply chain collapse. Going into COVID, Morphogen had scaled aggressively: bigger building, more staff, anticipating continued growth. When the world shut down and the growth stalled, those decisions became liabilities.

  Ben describes riding the first rebrand as long as possible before reaching a clear conclusion: the setup wasn't adding to the bottom line, and it wasn't personally fulfilling. The only path forward was to fix every mistake at once.

• 3:00 – The Failed Acquisition: First Public Account

  For the first time publicly, Ben shares that Morphogen received an acquisition offer a few years back. He'd always said he'd never sell, but shifting life priorities (kids getting older, financial pressures) made it worth exploring. Over roughly eight to nine months, the deal took shape: clear the financial slate, provide capital for a complete rebuild, give Ben a structured exit plan. Then the contractual terms arrived. "They basically lowballed us by an embarrassing amount."

  Ben spent a few months feeling like "the captain of a sinking ship." Once that cleared, he realized every idea he'd been developing for the next version of Morphogen was still his to build, and he went to work.

• 5:00 – David DeMesquita: The Missing Third Partner

  About a year and a half ago, Ben brought on David DeMesquita as co-formulator and outreach manager. David is a former John Meadows protégé who has coached high-level Olympia athletes and has a broad network across the industry. He joined right as the current rebrand was kicking off, timing Ben calls "almost a perfect storm."

  Ben describes David as the "third leg of the stool" that he and Dedra had been missing for years. Where Ben leads on creative vision and Dedra manages operations and finances, David brings formula depth, industry relationships, and the ability to represent the brand at events and get into rooms Morphogen hadn't previously accessed.

• 8:45 – Business Lessons: Termites at the Foundation

  The decade of growth made it easy to ignore structural problems. Ben's analogy: you can build a mansion with granite countertops and perfect fixtures, but if you ignore the termites at the foundation, they'll eventually take the whole thing down. In the good years, rolling debt felt manageable. Until it didn't. Even at their highest-ever sales year, net profit was "pretty abysmal."

  The lesson he'd give any younger brand owner: get your financial structure right before chasing creative expansion. Don't place a PO unless the math supports it. Don't spend a cent unless that cent makes sense. And don't scale headcount based on optimistic projections that haven't materialized yet.

• 12:30 – Best Formulas Ever, Healthiest Margins Ever

  Ben's framing for the current product line is blunt: "These are overwhelmingly the best formulas we've ever put out. And I can tell you that these are the healthiest profit margins we've ever had in terms of cost of goods." He got both at once by putting his creative instincts inside a hard financial template and refusing to break it.

  

  Morphogen Nutrition just dropped major upgrades to ALPHAGEN and VOLUGEN pre-workouts. That 10g L-tyrosine dose is back, plus some serious formula improvements that caught our attention. These work solo or stacked for maximum flexibility.

  Ben Kane draws a sharp analogy: every serious bodybuilder eventually hits a phase where obsessing over fundamentals produces better results than pushing extremes. That's what Morphogen went through at the business level. The art didn't disappear -- it just had to earn its place within a structure that actually worked.

• 13:15 – Hero vs. Backup Ingredients: Supply Chain and Formula Thinking

  Every formula has hero ingredients and backup ingredients. You can't have 40 heroes. Ben admits he used to watch competitor moves closely and felt pressure to include whatever ingredient was trending. He's shed that habit and says it makes him better at what he does: "When I make decisions based on what's going on out there, things go bad."

  The threshold isn't always a trademarked form, either. A good-quality generic raw can accomplish the goal without the sourcing volatility or claims constraints that come with a specific branded version. The real test: does the formula as a complete system deliver noticeably effective results? That's the only standard that matters.

• 18:30 – Diminishing Returns: “Racing to the Bottom”

  Ben recalls Chris Waldron of Inspired Nutraceuticals warning him years ago: "Be careful that you're not racing to the bottom." Past a certain point, stacking more ingredients produces diminishing returns, and customers lose the ability to distinguish effects from one compound to another. Ben includes himself in this: he personally can't isolate the effect of a single ingredient on top of an already-loaded daily stack.

  The benchmark he uses: does it make sense on paper, is the science credible, and will the target customer actually feel it? If any of those answers is uncertain, the case for including that ingredient weakens fast. Consumer feedback helps, but only when it can be separated from placebo effects, caffeine withdrawal, and the dozens of other variables in play.

• 20:30 – Breaking the Debt Cycle: PO Discipline and the Move to 3PL

  The fix for rolling debt came down to one rule: debt money isn't your money. On every purchase order, 50% goes down immediately, and the remaining 50% sits in a separate savings account until goods arrive and clear inspection. If they didn't have the full amount set aside, they didn't place the order. This slowed inventory growth for a while but permanently stopped the bleeding.

  

  The building (bought just before COVID, sold after it doubled in value) generated enough proceeds to roughly break even on the overall outlay. Morphogen moved all fulfillment to a nearby 3PL partner. Fewer errors than the old in-house staff, lower overhead, zero facilities management. Ben says he wishes he'd made the move a decade earlier.

• 27:45 – ALPHAGEN Reborn: The 10g L-Tyrosine Decision

  After a prior version that went "80% of the way" trying to reach a broader market, which alienated the core audience instead, Ben returned to his formula roots. The main complaint on that version: some users felt that L-Theanine in combination with other ingredients was sedating. Ben took it out and restored the original approach. "I'm putting that tyrosine back in there. I loved it."

  The current ALPHAGEN is built around 10g L-Tyrosine, 400mg Caffeine, 8g L-Citrulline, 3.2g Beta-Alanine, 2.5g Betaine Anhydrous, 300mg GeniusPure® Alpha-GPC (90%), 250mg Citicoline (CDP-Choline), Uridine 5'-Monophosphate, 508mg VasoDrive-AP®, Velvet Bean (Mucuna pruriens) for L-DOPA, and Eria Jarensis (N-Phenethyl Dimethylamine Citrate). Ben Kane calls the focus stack "really solid."

• 30:15 – Eria Jarensis, Manufacturing Partners, and Label Honesty

  Ben is candid about Eria Jarensis: it's GRAS as a food ingredient and flavoring agent (our article shows where it has GRAS listings and is on EAFUS). "It's been used for ten years and nobody's gotten hurt from it." He's aware it may need to come out if Morphogen expands into NSF-certified wholesale channels. Most GMP manufacturers handle it without issue.

  The label transparency conversation follows. AlphaGEN voluntarily lists a Vitamin A declaration from its Advantra Z® bitter orange / synephrine content, something legally optional but worth disclosing. Ben sees similar gaps: mushroom-based products (like ADAPTOGEN) that list zero carbs when the math doesn't support it, and citicoline sodium formulas that omit the sodium. If it's in the product, it belongs on the label.

• 35:15 – PRIME: Origin Story and the Anchor Health Product

  "Prime is kind of the granddaddy. I made the original Prime for my dad." With family history of heart disease on both sides, Ben wanted everything his father needed in one capsule serving. PRIME has been out roughly eight to nine years and is now Morphogen's top-selling product, having surpassed CALM in the past few years.

  

  Every other health supplement in the Morphogen catalog is built around PRIME's dosing foundation. HEART + LIPIDS adds 1,000mg Arjuna on top of PRIME's base dose. LIVER TUDCA provides 600mg NAC (N-acetyl cysteine) to stack with PRIME's NAC content, hitting a full therapeutic range together. The design intent is deliberate: PRIME comes first, and the other products extend it rather than duplicate it.

• 40:30 – AstraGin® and BioPerine®: Choosing Absorption Enhancers Wisely

  Mike asks how Ben deploys AstraGin® (from NuLiv Science) and BioPerine® across his product line. He confirmed with a NuLiv Science scientist that AstraGin®'s upper limit is in gram quantities, well above any realistic stacked daily dose, and reserves it for botanical-heavy products where complex ingredient absorption benefits most.

  BioPerine® is a different calculation. Its mechanism involves liver metabolism, and stacking it across multiple products can push people into ranges that cause gastric distress or skew bloodwork. Ben matches each enhancer to the ingredient type: AstraGin® for complex botanicals, BioPerine® only where it mechanistically fits. Pairing it with simple synthetics signals a brand that either doesn't know or doesn't care.

• 46:30 – CALM: From Bodybuilding Contest Prep to Gen Pop

  CALM's origin is older than it looks. Fifteen-plus years ago, Ben was using a now-defunct brand's product built around Phosphatidylserine (PS) and DIM (Diindolylmethane) for cortisol and estrogen management during contest prep. He built CALM from that foundation for competitive bodybuilders, and it crossed over to gen pop.

  He currently uses Shoden® ashwagandha (35% withanolides, a higher yield than KSM or Sensoril) because the concentration fits what the product is trying to accomplish. A former sleep product used Sensoril for its distinct mechanism. On ashwagandha anhedonia: Ben suspects the threshold is well above what most people realistically hit through stacking, but Morphogen deliberately avoids adding ashwagandha to products where cumulative line dosing could push someone over an individual sensitivity threshold.

• 51:15 – “I Don’t Listen to My Customers”

  

  Ben dropped this line on a recent Q&A, and here he explains it. Customers can't accurately self-report single-ingredient effects because they're almost never controlling for enough variables. One customer was convinced CALM was causing migraines. After several email exchanges, it turned out she'd stopped drinking coffee the same week she started the product. Caffeine withdrawal. Another six-year customer felt the products had "stopped working." Ben's read: she's six years older, possibly due for blood work and a hormone panel, not a formula change.

  The formula is "overwhelmingly better than what we put out five years ago." What changed is the person using it. Supplements don't get credit in self-attribution -- but neither do they deserve the blame.

• 54:45 – Blood Work, Hormones, and Realistic Self-Assessment

  Deficiencies and toxicities accumulate slowly. You won't go B12-deficient overnight after going vegan, and you won't feel a metabolic correction in 48 hours. Blood work is the only honest readout. Female competitors face a harder version of this: Ben's advice is to not compete more than once per year, and to take a full year off between diet phases. He's seen long-term metabolic and thyroid fallout play out repeatedly among influencers who went too hard for too long.

  The section takes a brief turn through functional health market dynamics. The PCOS-to-PMOS reclassification is legitimate science. The way some functional coaches are selling it, however, treats caloric thermodynamics as optional, and Ben isn't buying that framing.

• 1:01:30 – The Nick Walker Partnership: How It Actually Happened

  After David DeMesquita joined, the team evaluated roughly ten high-level IFBB pros before Nick Walker came into focus. The process was deliberately slow. Early calls weren't about business at all, just getting to know each other and talking about family and life. Ben met Nick's parents. The alignment had to be personal before it was professional.

  Nick's "The Mutant" identity in bodybuilding is real, but Ben describes him as a genuinely normal person who moved to Florida, bought the cars, went to Vegas, and decided within a year that life was "stupid." He moved back home to be near family, live simply, and compete because he still loves it.

• 1:04:30 – Equity, Not a Paycheck: “We Gave It to Him”

  

  The online speculation about the financial terms gets corrected here directly: "He didn't give us any money to buy into the company. We gave it to him." Ben wanted someone invested in the long-term the same way he is, not a salaried employee chasing discount-code commissions. When Ben asked where Nick saw himself in five years, Nick said: "I want to take care of my family. That's it." That locked it in.

  The impact was immediate. The partnership was announced in mid-February 2026. In the second half of that month, sales doubled compared to the first half. Nick has a discount code (NICKWALKER), but the lift went far beyond anything the code traffic could explain.

• 1:11:30 – Nick’s Feedback, Carb Fuel, and PROTEGEN on the Way

  Nick still uses other brands' protein powders because Morphogen's has been in transition during the rebrand. He's given one specific product request: during contest prep, he eliminates dietary sugar as much as possible, which means he won't use Morphogen's Carb Fuel intra-workout powder (a mix of Cluster Dextrin® / Highly Branched Cyclic Dextrin, Dextrose, and Ribose). He wants a plain Cluster Dextrin® option with zero sugar declared. Ben doesn't personally agree with the approach, but acknowledges 10,000 customers probably share the preference.

  PROTEGEN, a whey-isolate recovery protein with additional recovery-specific ingredients Ben won't detail yet, has four flavors in production and is expected within roughly six weeks. The first two items in Nick Walker's signature line will be two ProteGEN flavors.

• 1:16:45 – From Bodybuilding Brand to Health and Wellness

  The performance products that used to top Morphogen's sales charts have slipped well down the overall rankings. PRIME and CALM are now the leaders by a significant margin. Ben sees the Nick Walker partnership as the catalyst to rebuild the performance side, but at a broader level, the same identity shift is playing out across the industry: former pros retire, their audiences evolve, and health-focused products reach demographics that performance brands never could.

  The trend lines he's watching include CrossFit migrating to Hyrox, the enhanced-athlete and biohacker overlap, and the mainstream use of peptides following the GLP-1 wave. All of them point toward a health-and-performance convergence that Morphogen has been building toward for years.

• 1:21:30 – The Longevity Wave: NMN, Urolithin A, and Mitochondrial Health

  

  Ben points to NMN (Nicotinamide Mononucleotide) and Urolithin A as early indicators of where the longevity market is heading. Both are already showing up in sports performance contexts, with Urolithin A gaining traction among Hyrox athletes for endurance and mitochondrial benefits. Commodity versions are selling for $80 to $100 a month, premium territory reserved for branded, clinically studied forms.

  A top-secret Q4 product is teased here. Ben calls it a "first of its kind" category fitting the longevity/biohacking trajectory, combining ingredients he and David don't think have ever been paired in a formula. No details. Every time he's shared a concept publicly, a competitor has had a similar product on shelves within 12 weeks.

• 1:27:00 – Natural vs. Enhanced: An Honest Reassessment

  Ben Kane asks whether "being natural" still matters to Ben Hartman, who competed as a natural bodybuilder starting in 2004. The short answer is no, with a caveat. He's not saying "full send everything." He means the dogmatic framing that refuses any enhancement no longer holds up, especially given what's available in the peptide space and with responsible hormone replacement therapy in your mid-40s.

  His broader point: the line between "supplement" and "drug" often comes down to regulatory history more than biochemistry. The same logic that allowed competitors to use concentrated Phosphatidylserine and DIM under the "natural" banner applies to a growing range of peptides with reasonable safety profiles. The real standard should be educated use with medical oversight, not a category label.

• 1:35:00 – The Supplements That Actually Moved the Needle

  Ben Kane asks which supplements produced genuinely observable results for Ben personally. Ben traces his 2012 competitive season (his best ever) to using the original AlphaGEN two to three times per day through prep. Energy, focus, and training performance stayed consistent even as calories dropped hard. He's convinced that result wasn't replicable with coffee alone.

  Ben Kane adds GlucoVantage® (dihydroberberine) by NNB Nutrition to the list, citing visible body composition changes within days and weeks. Ben's core view: most single ingredients added to an already-dialed-in protocol won't be individually perceptible. The formula as a complete system, combined with consistent blood work, is what reveals real effects.

• 1:38:00 – Stimulant Nostalgia: DMAA, Ephedrine, and What’s Still Available

  The conversation ends with a candid trip down memory lane. Ben calls DMAA (1,3-Dimethylamylamine) "probably the GOAT of stims. I've never felt as good as that." Mike agrees it delivered both mind and body, unlike ephedrine, which he describes as more of a body rush. Ephedrine Sulfate (available via Bronkaid®) is still accessible at most pharmacies. The DMHA variants, by contrast, left Ben feeling "like absolute trash".

  For those curious about old-school stacks, Mike suggests pairing a nitric oxide booster with half a Bronkaid® tablet. Ben's own LEAN (fat burner, currently being reformulated) uses botanical ingredients he says feel closer to ephedrine than synephrine (Advantra Z®) in terms of perceived effect.

• 1:40:45 – Dedra Hartman (CFO) and Closing Thoughts

  Mike closes by asking about Dedra Hartman ("Deeds"), Ben's wife and CFO. Her role: contractual management, backend logistics, overseeing their part-time customer service rep, accounts reconciliation, and (in Ben's words) "running me back in" when he's about to spend money that doesn't need to be spent. Ben is self-admittedly good at creative decisions and poor at financial guardrails. Dedra is the counterweight.

  Together with David DeMesquita handling formula development and outreach, Morphogen now has the three-seat table Ben had been missing for years. The product pipeline is deep, the business structure is clean, and Nick Walker-driven brand awareness is opening doors to athletes, wholesale accounts, and audiences that weren't reachable before.

Where to Follow and Learn More

Connect with Ben Hartman and Morphogen Nutrition

• LinkedIn: Ben Hartman
• Instagram: @morphogenben
• Instagram: @morphogen_nutrition
• Nick Walker: @nick_walker39 (discount code: NICKWALKER)
• Dedra Hartman: @fitdeeds
• Morphogen Nutrition Website
• Morphogen Nutrition on PricePlow — sign up for news and product alerts

Resources Mentioned

• Episode #033: The Rise of Morphogen Nutrition with Ben Hartman
• Episode #063: Morphogen Nutrition Rebrands - Ben Hartman #2
• Morphogen ALPHAGEN & VOLUGEN: The Ultimate Pre-Workout Duo
• Morphogen PRIME: Powerhouse Health Supplement
• Morphogen CALM: Stress + Anxiety Support
• Morphogen KIDNEY: Advanced Renal Protection
• Morphogen Adaptogen
• Eria Jarensis / N-Phenethyl Dimethylamine: Ingredient Deep Dive
• John Meadows' Supplement Stack

Products Discussed

• ALPHAGEN (stim pre-workout)
• VOLUGEN (non-stim pre-workout)
• PRIME (Full Spectrum Organ Health)
• CALM
• HEART + LIPIDS
• LIVER TUDCA
• BIOME (gut health)
• BOLIC (recovery/muscle)
• Full Morphogen Nutrition lineup on PricePlow

Thanks to Ben Hartman for the most detailed look at Morphogen's business and formula philosophy in years. The operational rebuild is clearly paying off, and with the Nick Walker partnership accelerating brand awareness and the longevity product lineup still expanding, there's a lot to watch heading into the second half of 2026. Sign up for Morphogen Nutrition alerts on PricePlow to catch every launch as it drops.

This episode is brought to you by PerfectShaker, makers of the original BlenderBottle and some seriously premium shaker cups. Check them out at PricePlow.com/perfect-shaker or PerfectShaker.com, and if you want to hear the full PerfectShaker story, Darren Thompson sat down with us in Episode #209.

Subscribe to the PricePlow Podcast on any platform, sign up for Morphogen Nutrition news on PricePlow, and leave us a great review on iTunes and Spotify!

Subscribe to the PricePlow Podcast on Your Favorite Service (RSS)

Apple Podcasts

Spotify

YouTube